Safety and Efficacy Analysis of Apixaban Compared to Heparins in Hospitalized Non-Critically Ill COVID-19 Patients

Authors

Daniel Appiah
Nicholas J. Quinn
Emily G. Messing
Keith T. Veltri, Touro College of PharmacyFollow

Roles

Author

Document Type

Article

Publication Date

1-1-2022

Recommended Citation

Appiah, D., Quinn, N. J., Messing, E. G., & Veltri, K. T. (2022). Safety and Efficacy Analysis of Apixaban Compared to Heparins in Hospitalized Non-Critically Ill COVID-19 Patients. Hospital Pharmacy, 57 (6), 727-733. https://doi.org/10.1177/00185787221095764